Renuvion Safely and Effectively Treats Lax Skin in Trial
In a Phase II study, the Renuvion device improved the appearance of lax skin in 82.5% of subjects after 6 months.
In a Phase II study, the Renuvion device improved the appearance of lax skin in 82.5% of subjects after 6 months.
A new ISAPS report shows a facial procedure has overtaken liposuction as the most-performed surgery worldwide.
Study results presented at EADV 2025 show nearly half of initial complete responders maintained clearance over four years.